Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |